Glaukos (GKOS) Depreciation & Amortization (CF) (2014 - 2026)

Glaukos' (GKOS) quarterly Depreciation & Amortization (CF) came in at $11.8 million in Q1 2026, up 43.39% year-on-year from $8.2 million in Q1 2025, and down 3.02% on a QoQ basis from $12.2 million in Q4 2025.

Glaukos (GKOS) Depreciation & Amortization (CF) (2014 - 2026) Analysis & Trends

Glaukos (GKOS) has 13 years of Depreciation & Amortization (CF) data on file, last reported at $11.8 million in Q1 2026.

  • On a quarterly basis, Depreciation & Amortization (CF) rose 43.39% year-over-year to $11.8 million in Q1 2026; TTM through Mar 2026 was $41.7 million, a 19.16% increase from a year earlier, with the FY2025 full-year figure at $38.1 million, up 6.85% from the prior year.
  • Depreciation & Amortization (CF) for Q1 2026 stood at $11.8 million, down from $12.2 million in the prior quarter.
  • Over the last five years, Depreciation & Amortization (CF) for GKOS reached as high as $26.9 million in Q4 2022 and fell as low as $1.4 million in Q1 2022.
  • Historically, Depreciation & Amortization (CF) has averaged $7.4 million across 5 years, with a median of $8.6 million in 2025.
  • Across the five-year window, Depreciation & Amortization (CF) plunged 91.49% in 2023 and jumped 328.92% in 2024, its largest moves.
  • Year by year, Depreciation & Amortization (CF) stood at $26.9 million in 2022, then plunged by 91.49% to $2.3 million in 2023, then soared by 282.16% to $8.7 million in 2024, then surged by 39.18% to $12.2 million in 2025, then fell by 3.02% to $11.8 million in 2026.
  • Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $11.8 million in Q1 2026, $12.2 million in Q4 2025, and $9.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 381.00 Mn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 120.00 Mn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 716.00 Mn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 351.00 Mn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 40.90 Mn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 67.10 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 310.25 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 78.00 Mn
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Glaukos 8.83 Bn 8.73 Bn 117.23 Mn 11.80 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 11.80 Mn
Mar 31, 2026 11.80 Mn
Dec 31, 2025 12.16 Mn
Dec 31, 2025 12.16 Mn
Sep 30, 2025 9.13 Mn
Sep 30, 2025 9.13 Mn
Jun 30, 2025 8.57 Mn
Jun 30, 2025 8.57 Mn
Mar 31, 2025 8.23 Mn
Mar 31, 2025 8.23 Mn
Dec 31, 2024 8.74 Mn
Dec 31, 2024 8.74 Mn
Sep 30, 2024 9.00 Mn
Sep 30, 2024 9.00 Mn
Jun 30, 2024 9.00 Mn
Jun 30, 2024 9.00 Mn
Mar 31, 2024 8.91 Mn
Mar 31, 2024 8.91 Mn
Dec 31, 2023 2.29 Mn
Dec 31, 2023 2.29 Mn